{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:52:59Z","timestamp":1790153579131,"version":"4.0.1"},"reference-count":45,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T00:00:00Z","timestamp":1307059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Basic Clin Pharma Tox"],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Increased expression of matrix metalloproteinase (MMP)\u20102, \u20103 and \u20109 has been demonstrated in Crohn\u2019s disease fistulas, but it is unknown whether these enzymes are biologically active and represent a therapeutic target. Therefore, we investigated the proteolytic activity of MMPs in fistula tissue and examined the effect of inhibitors, including clinically available drugs that beside their main action also suppress MMPs. Fistula specimens were obtained by surgical excision from 22 patients with Crohn\u2019s disease and from 10 patients with fistulas resulting from other causes. Colonic endoscopic biopsies from six controls were also included. Total functional MMP activity was measured by a high\u2010pressure liquid chromatography (HPLC)\u2010based, fluorogenic MMP\u2010substrate cleavage assay, and the specific activity of MMP\u20102, \u20103 and \u20109 by the MMP Biotrak Activity Assay. The MMP inhibitors comprised ethylene\u2010diamine\u2010tetraacetic acid (EDTA), the synthetic broad\u2010spectrum inhibitor, GM6001, the angiotensin\u2010converting enzyme (ACE) inhibitor, ramiprilate, and the tetracycline, doxycycline. In Crohn\u2019s disease fistulas, about 50% of the total protease activity was attributable to MMP activity. The average total MMP activity was significantly higher (about 3.5\u2010times) in Crohn\u2019s fistulas (471\u2003FU\/\u03bcg protein, range 49\u20132661) compared with non\u2010Crohn\u2019s fistulas [134\u2003FU\/\u03bcg protein, range 0\u2013495, (<jats:italic>p<\/jats:italic>\u2003&lt;\u20030.05)] and normal colon [153\u2003FU\/\u03bcg protein, range 77\u2013243, (<jats:italic>p<\/jats:italic>\u2003&lt;\u20030.01)]. MMP\u20103 activity was increased in Crohn\u2019s fistulas (1.4\u2003ng\/ml, range 0\u20139.83) compared with non\u2010Crohn\u2019s fistulas, [0.32\u2003ng\/ml, range 0\u20132.66, (<jats:italic>p<\/jats:italic>\u2003&lt;\u20030.02)]. The same applied to MMP\u20109 activity [0.64\u2003ng\/ml, range 0\u20135.66 and 0.17\u2003ng\/ml, range 0\u20131.1, respectively (<jats:italic>p<\/jats:italic>\u2003&lt;\u20030.04)]. Ramiprilate significantly decreased the average total MMP activity level by 42% and suppressed the specific MMP\u20103 activity by 72%, which is comparable to the effect of GM6001 (87%). Moreover, MMP\u20109 activity was completely blunted by ramiprilate. Doxycycline had no effect on MMP activity. Increased functional MMP activity, notably MMP\u20103 and \u20109, is present in Crohn\u2019s fistulas and may be inhibited by ramiprilate, a widely available ACE inhibitor.<\/jats:p>","DOI":"10.1111\/j.1742-7843.2011.00713.x","type":"journal-article","created":{"date-parts":[[2011,4,28]],"date-time":"2011-04-28T14:55:26Z","timestamp":1304002526000},"page":"208-216","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Ramiprilate Inhibits Functional Matrix Metalloproteinase Activity in Crohn\u2019s Disease Fistulas"],"prefix":"10.1111","volume":"109","author":[{"given":"Eva","family":"Efsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben","family":"S\u00e6rmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eywin","family":"Bruun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rn","family":"Brynskov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,6,3]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.49.suppl_4.iv2"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199905063401804"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.159251"},{"key":"e_1_2_5_5_2","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.4049\/jimmunol.160.8.4098","article-title":"A p55 TNF receptor immunoadhesin prevents T cell\u2010mediated intestinal injury by inhibiting matrix metalloproteinase production","volume":"160","author":"Pender SL","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.158.4.1582"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-9525(90)90126-Q"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1515\/BC.2003.097"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70339-2"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01227.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3283293d0f"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i37.6050"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:DDAS.0000026314.12474.17"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2008.03836.x"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.90454.2008"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.6.4103"},{"key":"e_1_2_5_17_2","first-page":"1802","article-title":"Vanadate, an inhibitor of stromelysin and collagenase expression, suppresses collagen\u2010induced arthritis","volume":"34","author":"Oliver SJ","year":"2007","journal-title":"J Rheumatol"},{"key":"e_1_2_5_18_2","first-page":"2761","article-title":"Serum matrix metalloproteinase 3 in early rheumatoid arthritis is correlated with disease activity and radiological progression","volume":"27","author":"Posthumus MD","year":"2000","journal-title":"J Rheumatol"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.154831"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-006-0438-3"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.017442"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.02.013"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpgasthep1340"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.038208"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(92)80300-6"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M408523200"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990531)81:5<761::AID-IJC16>3.0.CO;2-1"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2613.2008.00634.x"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i31.4807"},{"key":"e_1_2_5_30_2","first-page":"1985","article-title":"Captopril inhibits glioma cell invasion in vitro: involvement of matrix metalloproteinases","volume":"15","author":"Nakagawa T","year":"1995","journal-title":"Anticancer Res"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000168945.44069.aa"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2008.09.037"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262090-00016"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1080\/02841860310022346"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4644(19960301)60:3<341::AID-JCB6>3.0.CO;2-W"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.30.469"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005827119296"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-210-43942"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-196-43189"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.108.174367"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2007.10.011"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000129334.05181.b6"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0765.2004.00696.x"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1067\/mva.2002.125018"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1258\/rsmvasc.13.5.290"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-005-0025-4"}],"container-title":["Basic &amp; Clinical Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-7843.2011.00713.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1742-7843.2011.00713.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T17:51:27Z","timestamp":1697305887000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-7843.2011.00713.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.1111\/j.1742-7843.2011.00713.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1742-7843.2011.00713.x","archive":["Portico"],"relation":{},"ISSN":["1742-7835","1742-7843"],"issn-type":[{"value":"1742-7835","type":"print"},{"value":"1742-7843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,3]]},"assertion":[{"value":"2011-06-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}